145 related articles for article (PubMed ID: 6569428)
1. PPA: an innocent over-the-counter drug?
Ludwikowski KL
Pediatr Nurs; 1984; 10(6):387-90. PubMed ID: 6569428
[No Abstract] [Full Text] [Related]
2. Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction.
Pilsczek FH; Karcic AA; Freeman I
Heart Lung; 2003; 32(2):100-4. PubMed ID: 12734532
[TBL] [Abstract][Full Text] [Related]
3. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products.
McEwen J
Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050
[TBL] [Abstract][Full Text] [Related]
4. Combining nonprescription medications.
Shuster J
Nursing; 1998 Jun; 28(6):77. PubMed ID: 9668801
[No Abstract] [Full Text] [Related]
5. Neurologic signs and symptoms related to over-the-counter diet pills.
Mueller SM; Graham JD; Duggan D
Indiana Med; 1985 May; 78(5):388-90. PubMed ID: 3998456
[No Abstract] [Full Text] [Related]
6. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant.
Smookler S; Bermudez AJ
Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595
[TBL] [Abstract][Full Text] [Related]
7. FDA issues public health advisory on phenylpropanolamine in drug products.
Meadows M
FDA Consum; 2001; 35(1):9. PubMed ID: 11930934
[No Abstract] [Full Text] [Related]
8. Nonprescription appetite suppressants.
Drew R
N C Med J; 1983 Sep; 44(9):573-4. PubMed ID: 6579375
[No Abstract] [Full Text] [Related]
9. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
Greenway F; Herber D; Raum W; Herber D; Morales S
Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
[TBL] [Abstract][Full Text] [Related]
10. Cerebral infarction with a single oral dose of phenylpropanolamine.
Edwards M; Russo L; Harwood-Nuss A
Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020
[TBL] [Abstract][Full Text] [Related]
11. Phenylpropanolamine hydrochloride.
Williams DM
Am Pharm; 1990 Oct; NS30(10):47-50. PubMed ID: 2239691
[TBL] [Abstract][Full Text] [Related]
12. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.
Mersfelder TL
Cleve Clin J Med; 2001 Mar; 68(3):208-9, 213-9, 223. PubMed ID: 11263849
[TBL] [Abstract][Full Text] [Related]
13. Over-the-counter phenylpropanolamine: a possible cause of central retinal vein occlusion.
Gilmer G; Swartz M; Teske M; Crandall AS
Arch Ophthalmol; 1986 May; 104(5):642. PubMed ID: 3707408
[No Abstract] [Full Text] [Related]
14. The PPA blues. What do you do when scientists tell you that the bottles in your medicine chest can kill you?
Smith IK
Time; 2000 Oct; 156(18):101. PubMed ID: 11185359
[No Abstract] [Full Text] [Related]
15. Neurological and cardiac events on phenylpropanolamine.
Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819
[TBL] [Abstract][Full Text] [Related]
16. Obesity.
Arterburn D
Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
[No Abstract] [Full Text] [Related]
17. Clinical studies with phenylpropanolamine: a metaanalysis.
Greenway FL
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
[TBL] [Abstract][Full Text] [Related]
18. Over-the-counter stroke?
Ornato JP
Health News; 2000 Dec; 6(12):3. PubMed ID: 11142938
[No Abstract] [Full Text] [Related]
19. An estimation of the toxicity of non-prescription diet aids from seventy exposure cases.
Ekins BR; Spoerke DG
Vet Hum Toxicol; 1983 Apr; 25(2):81-5. PubMed ID: 6845628
[No Abstract] [Full Text] [Related]
20. Hypertension due to anorectic agent.
Shapiro SR
N Engl J Med; 1969 Jun; 280(24):1363. PubMed ID: 5783669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
